Hamilton anxiety rating scale

Ham·il·ton anxiety rating scale

(ham'ĭl-tŏn),
a list of specific symptoms used as a measure of severity of anxiety.

Ham·il·ton an·xi·e·ty rat·ing scale

(hamil-tŏn ang-zīĕ-tē rāting skāl)
A list of specific symptoms used as a measure of severity of anxiety.

Ham·il·ton an·xi·e·ty rat·ing scale

(hamil-tŏn ang-zīĕ-tē rāting skāl)
List of specific symptoms used as a measure of severity of anxiety.
References in periodicals archive ?
42 MG = myasthenia gravis; SD = standard deviation; IQR = interquartile range; QMGS = quantified myasthenia gravis score; BDI-II = Beck Depression Inventory (<13 = minimal; 14-19 = mild; 20-28 = moderate); HAM-A = Hamilton Anxiety Rating Scale (14-17 = mild; 18-24 = moderate); BPRS = Brief Psychiatric Rating Scale (0-31 = mildly ill); YMRS = Young Mania Rating Scale (8-12 = hypomania).
The efficacy assessments from baseline to week 6 were based on the Hamilton Anxiety Rating Scale (HAM-A) as an objective measure of the severity of anxiety symptoms.
The 14-item Hamilton Anxiety Rating Scale (HAM-A) and the 21-item Hamilton Depression Rating Scale (HAM-D) were used at baseline and at weekly intervals.
79), as well as significant improvement on all secondary measures, including the Hamilton Depression Rating Scale (HAMD), the Clinical Global Impressions--Improvement (CGI-I) and--Severity (CGI-S) scales, and the Hamilton Anxiety Rating Scale, according to Dr.
The subjects were required to complete a questionnaire designed by the authors, and were then rated by one of the authors (COM, who is a psychiatrist) on the Hamilton Anxiety Rating Scale (HARS).
In the other forty-one patients, the levels of depression, anxiety and quality of life were assessed with the Hamilton Depression Rating Scale (HDRS) (27,28), the Hamilton Anxiety Rating Scale (HARS) (29,30) and the World Health Organization Quality of Life Assessment Brief (WHOQOL-BREF) (31,32), respectively.
Eli Lilly has used a professional sales aid for Strattera that includes the phrase "not contraindicated in patients with anxiety" and includes a graph showing the mean change from baseline for Strattera and placebo on the Hamilton Anxiety Rating Scale.
The primary endpoint is statistically significant improvement in Hamilton Anxiety Rating Scale scores as compared to placebo.
There was also a statistically significant improvement in symptoms of anxiety associated with depression, as measured by the Hamilton Anxiety Rating Scale (HAMA, p=0.
Anxiety symptom severity was rated using the Hamilton Anxiety Rating Scale (HAM-A), depression was assessed using the Hamilton Depression Rating Scale (HAM-D), psychosocial functioning was evaluated using the Sheehan Disability Scale (SDA), and quality of life was evaluated with the Quality of Life Inventory.
Psychiatric assessments were performed using the Montgomery-Asberg Depression Rating Scale (MADRS) and the Hamilton Anxiety Rating Scale.
Full browser ?